ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT00116779

Public ClinicalTrials.gov record NCT00116779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Randomized, Multi-center, Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer Dosed for Thirteen 28-day Cycles

Study identification

NCT ID
NCT00116779
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
127 participants

Conditions and interventions

Interventions

  • Degarelix Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2004
Primary completion
Jul 31, 2005
Completion
Jul 31, 2005
Last update posted
Dec 18, 2011

2004 – 2005

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
26
Facility City State ZIP Site status
Urology Centers of Alabama Homewood Alabama 35209
Alaska Clinical Research Center, LLC Anchorage Alaska 99508
Advanced Urology Medical Center Anaheim California 92801
South Orange County Medical Research Cnter Laguna Woods California 92653
Pacific Clinical Research Santa Monica California 90404
West Coast Clinical Research Tarzana California 91356
Western Clinical Research Torrance California 90505
Urology Associate PC Denver Colorado 80210
South Florida Medical Research Aventura Florida 33180
SW Florida Urological Associates Fort Myers Florida 33907
Florida Foundation for Healthcare Research Ocala Florida 34474
RMD Clinical Reseach Institution LLC Melrose Park Illinois 60160
Northeast Indiana Research, LLC Fort Wayne Indiana 46825
Regional Urology Shreveport Louisiana 71106
Nevada Urology Associates Reno Nevada 89511
Lawrenceville Urology Lawrenceville New Jersey 08648
Hudson Valley Urology PC Poughkeepsie New York 12601
The Urology Center Greensboro North Carolina 27401
State College Urologic Association State College Pennsylvania 16801
Univeristy Urological Research Institute Providence Rhode Island 02904
Urology San Antonio Research San Antonio Texas 78229
Scott & White Memorial Hospital Temple Texas 76508
University of Vermont, Dept of Surgery South Burlington Vermont 05403
Virginia Urology Center Richmond Virginia 23235
Office of Jeffrey Frankel Seattle Washington 98166
Wyoming Research Foundation Cheyenne Wyoming 82001

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00116779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2011 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00116779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →